https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/dr-reddys-launches-migraine-management-device-in-europe/articleshow/109199979.cms
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=218034
https://www.business-standard.com/markets/capital-market-news/dr-reddy-s-labs-partners-with-bayer-for-second-brand-of-vericiguat-for-india-market-124040600101_1.html
https://www.aurigeneservices.com/sites/default/files/2024-04/Aurigene-Pharma-Aurigene.AI_.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217718
https://timesofindia.indiatimes.com/city/hyderabad/dr-reddys-lab-ties-up-with-pharmazz-to-market-centhaquine/articleshow/108723906.cms
https://www.globenewswire.com/news-release/2024/03/22/2850876/0/en/Pharmazz-Inc-and-Dr-Reddy-s-Laboratories-have-entered-into-a-licensing-agreement-to-market-Centhaquine-Lyfaquin-as-a-resuscitative-agent-for-hypovolemic-shock-in-India.html
https://www.indianpharmapost.com/news/dr-reddys-laboratories-launches-versavo-in-the-uk-15415
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/dr-reddys-gets-rs-74-22-cr-tax-demand-from-gst-authority/articleshow/108440872.cms?utm_source=contentofinterest&utm_medium=text&utm_campaign=cppst